Mary Conway

Davis Polk advised the joint book-running managers in connection with the $133.7 million initial public offering of common stock of Solid Biosciences Inc. The common stock is listed on the…

Davis Polk is advising KKR on its joint venture and related transactions with FS Investments. The transaction contemplates combining the business development company (BDC) businesses of KKR…

Davis Polk advised the underwriters in connection with an initial public offering of 5,333,333 shares of common stock of Allena Pharmaceuticals, Inc., at $14.00 per share, for total gross…

Davis Polk advised certain funds managed by Highbridge Capital Management, LLC in connection with the refinancing of the existing term loan facility for Inseego Corp. with a new three-year,…

Davis Polk is advising Dyal Capital Partners, a division of Neuberger Berman Group, on its strategic minority investment in Atalaya Capital Management. Dyal will become a passive, non…

Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 4,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk advised the sole book-running manager and representative of the underwriters in connection with the $200 million SEC-registered follow-on offering of 50,000,000 shares of common…

Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 7,000,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk advised Dyal Capital Partners II, a permanent capital fund affiliated with Neuberger Berman Group, on its acquisition of a minority stake in Sound Point Capital, LP. Financial…

Davis Polk advised the underwriters in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of Evolent’s existing stockholders…